Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Wellington Biomedical Innovation Master Investors Insider Profile
4 Followers
Wellington Biomedical Innovation Master Investors , Ten Percent Owner at Black Diamond Therapeutics, holds 801.62K shares in Zenas BioPharma, Inc. (Ticker: ZBIO), holds 194.11K shares in Artiva Biotherapeutics, Inc. (Ticker: ARTV), holds 556.23K shares in Boundless Bio Inc. (Ticker: BOLD).
Wellington Biomedical Innovation Master Investors Black Diamond Therapeutics (BDTX)Ten Percent Owner
Black Diamond Therapeutics (BDTX)
Ten Percent Owner
Ranked #63,235 out of 100,202 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-15.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Wellington Biomedical Innovation Master Investors 's holdings
Insider Roles
Roles that Wellington Biomedical Innovation Master Investors holds in companies
Most Profitable Insider Trade
The most profitable trade made by Wellington Biomedical Innovation Master Investors
Wellington Biomedical Innovation Master Investors 's Trading History
Black Diamond Therapeutics
Feb 05, 2020
Ten Percent Owner
Uninformative Buy
―
$1.26M
Generation Bio
Jun 18, 2020
Ten Percent Owner
Uninformative Buy
―
$2.51M
Forma Therapeutics Holdings
Jun 25, 2020
―
Uninformative Buy
―
$45.08M
Nurix Therapeutics
Jul 30, 2020
Ten Percent Owner
Uninformative Buy
―
$15.55M
Kymera Therapeutics
Aug 27, 2020
Ten Percent Owner
Uninformative Buy
―
$39.00M
Dyne Therapeutics
Sep 23, 2020
Ten Percent Owner
Uninformative Buy
―
$38.59M
PMV Pharmaceuticals
Sep 29, 2020
Former 10% Owner
Uninformative Buy
―
$1.14M
Aligos Therapeutics
Oct 22, 2020
Ten Percent Owner
Uninformative Buy
―
$75.94M
Olema Pharmaceuticals
Nov 24, 2020
Ten Percent Owner
Uninformative Buy
―
$10.52M
Edgewise Therapeutics
Mar 30, 2021
Ten Percent Owner
Uninformative Buy
―
$20.99M
Verve Therapeutics
Jun 22, 2021
Ten Percent Owner
Uninformative Buy
―
$14.32M
Nuvalent
Aug 03, 2021
Ten Percent Owner
Uninformative Buy
―
$75.60M
Boundless Bio Inc.
Apr 02, 2024
Ten Percent Owner
Uninformative Buy
―
$1.44M
Artiva Biotherapeutics, Inc.
Jul 22, 2024
Ten Percent Owner
Uninformative Buy
499.99K
$2.16M
Zenas BioPharma, Inc.
Sep 18, 2024
Ten Percent Owner
Uninformative Buy
―
$8.02M
List of latest transactions for each holding click on a transaction to see Wellington Biomedical Innovation Master Investors 's performance on stock
You May Also Like
Wellington Biomedical Innovation Master Investors insider profile FAQ
What is the percentage of profitable transactions made by Wellington Biomedical Innovation Master Investors ?
The percentage of profitable transactions made by Wellington Biomedical Innovation Master Investors is 50%.
What is the average return per transaction made by Wellington Biomedical Innovation Master Investors ?
The average return per transaction made by Wellington Biomedical Innovation Master Investors is -15.40%.
What stocks does Wellington Biomedical Innovation Master Investors hold?
Wellington Biomedical Innovation Master Investors holds: BDTX, GBIO, FMTX, NRIX, KYMR, DYN, PMVP, ALGS, OLMA, EWTX, VERV, NUVL, BOLD, ARTV, ZBIO stocks.
What was Wellington Biomedical Innovation Master Investors ’s latest transaction?
Wellington Biomedical Innovation Master Investors latest transaction was an Uninformative Buy of ―.
What was Wellington Biomedical Innovation Master Investors 's most profitable transaction?
Wellington Biomedical Innovation Master Investors ’s most profitable transaction was an Informative Buy of GBIO stock on June 18, 2020. The return on the trade was 12.40%.
What is Wellington Biomedical Innovation Master Investors 's role in Black Diamond Therapeutics?
Wellington Biomedical Innovation Master Investors 's role in Black Diamond Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.